株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

治験用品・ロジスティクスの世界市場 (2019~2029年):治験用品の製造/ロジスティクス・物流/サプライチェーン管理/包装/コールドチェーン・ロジスティクス

Clinical Trial Supply and Logistics Market for Pharma 2019-2029: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics

発行 Visiongain Ltd 商品コード 286489
出版日 ページ情報 英文 204 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1GBP=144.60円で換算しております。

ご注意:
Single UserとDepartmentalライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

Back to Top
治験用品・ロジスティクスの世界市場 (2019~2029年):治験用品の製造/ロジスティクス・物流/サプライチェーン管理/包装/コールドチェーン・ロジスティクス Clinical Trial Supply and Logistics Market for Pharma 2019-2029: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics
出版日: 2019年04月18日 ページ情報: 英文 204 Pages
概要

世界の治験用品・ロジスティクスの市場規模は、2018年段階で171億米ドルの規模となっており、その内の大半を製造分野が占めていました。2019~2024年のCAGR (複合年間成長率) は7.7%となる見通しです。

当レポートでは、世界の治験用品とそのロジスティクスの市場について分析し、全体的な市場動向の見通しや、地域別・主要国の詳細動向、関連規制の概要と近年の動向、業界の求心力・競争力の動向見通し、コールドチェーン・ロジスティクス分野の概況と動向見通し、主要企業のプロファイルといった情報を取りまとめてお届けいたします。

第1章 分析概要

第2章 治験用品・ロジスティクス市場:定義

第3章 世界の治験用品・ロジスティクス市場:展望と予測

  • 世界の治験用品・ロジスティクス市場:最新情勢
    • 主導権を握った部門はどれか?
  • 市場予測 (今後11年間分)
    • 市場促進要因
    • 市場抑制要因
  • 治験用品の製造市場
    • 市場の展望と予測 (今後11年間分)
    • 複合型製造・包装による成長促進
    • 治験用品の包装市場 (今後11年間分)
  • 治験用品のロジスティクス・物流市場
    • 市場予測 (今後11年間分)
    • 市場促進・抑制要因
    • 治験用品コールドチェーン物流市場 (今後11年間分)
  • 治験用品のサプライチェーン管理市場
    • 市場予測 (今後11年間分)
    • 市場促進・抑制要因

第4章 主要国の治験用品・ロジスティクス市場

  • 市場の定義
  • 世界各国の治験用品・ロジスティクス市場
    • 各国市場の成長見通し (今後11年間分)
  • 米国市場
    • 治験用品・ロジスティクス需要の成長見通し (今後11年間分)
    • 米国市場:部門別分析
  • 欧州主要5ヶ国 (EU5) 市場
    • ドイツ市場 (今後11年間分)
    • フランス市場 (今後11年間分)
    • 英国市場 (今後11年間分)
    • イタリア市場 (今後11年間分)
    • スペイン市場 (今後11年間分)
    • 欧州市場:部門別分析
  • 日本市場
    • 市場予測 (今後11年間分)
    • 日本市場:部門別分析
  • 新興国での治験需要の増加
  • 中国市場
    • 外資の進出状況
    • 今後の大幅成長の見通し (今後11年間分)
    • 中国市場:部門別分析
  • インド市場
    • 市場予測 (今後11年間分)
    • インド市場:部門別分析
  • ラテンアメリカ市場
    • 流通環境の変化
    • ブラジル市場 (今後11年間分)
    • ブラジル市場:部門別分析
  • ロシア市場 (今後11年間分)
    • EUとの近接性による利点
    • アウトソーシング部門の大幅成長
    • ロシア市場:部門別分析

第5章 治験用品・ロジスティクス市場:規制の展望

  • 規制基準が治験用品市場に及ぼす影響
    • 治験用品の流通過程における「適正基準」(GxP)
      • 適正製造基準 (GMP)
      • 適性流通基準 (GDP)
    • 輸入規制による影響
  • 米国国内の治験用品に対する規制
    • 米国への医薬品輸入:規制の再解釈
  • EU圏内の治験用品に対する規制
    • 治験用品の製造要件
    • 欧州委員会による新たな適性流通基準 (GDP) ガイドラインの発表
  • 日本国内の医薬品の適性流通基準 (GDP) および輸入規制
  • 新興国の治験用品サプライチェーン規制
    • 中国・インド・ブラジル・ロシアの規制動向

第6章 治験用品・ロジスティクス:産業動向

  • 治験用品・ロジスティクス市場:強みと弱み
  • 治験用品・ロジスティクス市場:機会と脅威
  • STEP分析
    • 社会的要因、技術的影響、経済的圧力、政治的問題
  • 治験用品のサプライチェーンの確保
    • ITによるサプライチェーン・セキュリティの改善
  • 治験のグローバル化が、治験用品・ロジスティクス市場に及ぼす影響
  • 治験用品の製造市場の動向 (今後11年間分)
    • 治験用対照薬の調達に関する課題
    • 治験用品のパッケージングの傾向 (今後11年間分)
  • 治験用品のサプライチェーン
    • 十分な供給量を確保するための、市場の予測とモデリング
    • ITシステムによる治験計画の改善:IVRS (双方向音声応答システム) とIWRS (双方向Web応答システム)
    • 在宅治験参加:ロジスティクス業者の機会と課題
    • 「適応的治験」の利用拡大が、治験用品ロジスティクスに及ぼす影響
  • 治験用品・ロジスティクスのアウトソーシング
    • 治験用品のネットワークの維持

第7章 治験用品向けコールドチェーン・ロジスティクスの台頭

  • コールドチェーン供給・流通:概略
    • 治験用品市場におけるコールドチェーンの重要性
    • コールドチェーンの維持
  • コールドチェーン・ロジスティクスの規制の見通し
    • 国際航空輸送の規制・指針:温度感知ラベル
  • 治験用品ロジスティクス市場における、コールドチェーンのシェア拡大
    • 生物製剤の開発による需要促進
      • 生物製剤開発の新たな傾向
    • 新興国における医薬品コールドチェーン・ロジスティクス
  • 治験用品のコールドチェーン・ロジスティクスにおけるITの役割
    • 能動的/受動的温度管理
    • コールドチェーンの温度管理:様々な手法
      • 相変化材料の開発
      • サンプル輸送用に関する液体窒素の利点
    • 温度管理用RFIDの進歩
      • RFIDはバイオ医薬品企業の間に広まるのか?
    • コールドチェーン供給管理のための未来の技術
      • リユース型コールドチェーン包装の需要

第8章 治験用品・ロジスティクス市場:代表的企業

  • 3PLプロバイダー:治験用品の代表的な流通業者
    • World Courier
    • DHL
    • Marken
    • その他:FedEx、Biocair International Limited、Movianto
  • 治験用品メーカー:分野別市場のリーダー
    • Catalent Pharma Solutions
    • Patheon N.V.
    • Almac Group
    • Amatsigroup SAS
  • CRO (医薬品開発業務受託機関):治験用品・ロジスティクス市場における役割
    • PAREXEL International Corp.
  • その他の企業
    • Fisher Clinical Services (FCS)
    • Packaging Coordinators Inc. (PCI)
    • ADAllen Pharma
    • Sharp Packaging Services, LLC
    • Durbin PLC

第9章 分析結果

付録

図表

List of Tables

  • Table 2.1: Clinical Trials Registered by Location, December 2018
  • Table 3.1: R&D Outsourcing Market: Submarket Size ($bn) and Market Share (%) by Sector, 2018
  • Table 3.2: Clinical Trial Supply and Logistics Market: Submarket Size ($bn) and Market Share (%) by Sector, 2018
  • Table 3.3: Clinical Trial Supply and Logistics Market Revenue Forecast by Sector: Revenue ($bn), AGR (%) and CAGR (%), 2019-2023
  • Table 3.4: Clinical Trial Supply and Logistics Market Revenue Forecasts by Sector: Revenue ($bn), AGR (%) and CAGR (%), 2023-2029
  • Table 3.5: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2019-2029
  • Table 3.6: Clinical Trial Manufacturing Submarket: Submarket Size ($bn) and Submarket Share (%) by Sector, 2018
  • Table 3.7: Clinical Trial Manufacturing Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2019-2023
  • Table 3.8: Clinical Trial Manufacturing Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2023-2029
  • Table 3.9: Clinical Trial Packaging Submarket: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 3.10: Clinical Trial Logistics and Distribution Market: Submarket Size ($bn) and Submarket Share (%) by Sector, 2018
  • Table 3.11: Clinical Trial Logistics and Distribution Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2019-2023
  • Table 3.12: Clinical Trial Logistics and Distribution Market Revenue Forecast by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2023-2029
  • Table 3.13: Clinical Trial Cold Chain Logistics Submarket: Revenue Forecast($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 3.14: Clinical Trial Supply Chain Management Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.1: Clinical Trial Supply and Logistics Market: Market Size ($bn) and Market Shares (%) by Leading Country and Region, 2018
  • Table 4.2: Clinical Trial Supply and Logistics Market: Country Submarket Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.3: Clinical Trial Supply and Logistics Market: Leading National Market Share (%), 2018, 2023 and 2029
  • Table 4.4: US Clinical Trial Supply and Logistics Market Forecast Revenue ($bn), 2019-2029
  • Table 4.5: US Clinical Trial Supply and Logistics Submarkets Revenue Forecast($bn), 2019-2029
  • Table 4.6: EU5 Clinical Trial Supply and Logistics: Submarket Revenue Forecasts ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.7: The EU5 Clinical Trial Supply and Logistics Submarket: Market Size ($bn) and Market Shares (%), 2018
  • Table 4.8: Germany: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.9: France Clinical Trial Supply and Logistics Submarket: Revenue Forecast ($bn), AGR (%) and CAGR (%),2019-2029
  • Table 4.10: The UK: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.11: Italy: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.12: Spain: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.13: EU5 Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 4.14: Japan: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.15: Japanese Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 4.16: China: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.17: Chinese Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 4.18: India: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.19: Indian Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 4.20: Brazil: Clinical Trial Supply and Logistics Market: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.21: Brazil Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 4.22: Russia: Clinical Trial Supply and Logistics: Revenue Forecast ($bn), AGR (%) and CAGR (%), 2019-2029
  • Table 4.30: Russia Clinical Trial Supply and Logistics Submarkets Revenue Forecast ($bn), 2019-2029
  • Table 5.1: ICH Manufacturing Guidelines, 2001-2012
  • Table 6.1: Clinical Trial Supply and Logistics Market: Strengths and Weaknesses, 2019-2029
  • Table 6.2: Clinical Trial Supply and Logistics Market: Opportunities and Threats, 2019-2029
  • Table 6.3: Clinical Trial Supply and Logistics Market: STEP Analysis, 2019-2029
  • Table 6.4: Comparative Costs of Orphan and Non-Orphan Clinical Trials, 2015
  • Table 6.5: TransCelerate BioPharma Member Companies, 2018
  • Table 6.6: Benefits of Advanced Forecasting Tools for Clinical Trial Logistics
  • Table 6.7: Selected Clinical Trial Supply Forecasting Tools Available, 2016
  • Table 6.8: Selected IVRS/IWRS Tools Available for Clinical Trials, 2019
  • Table 6.9: Home-Based Clinical Trial Distribution: Advantages and Disadvantages, 2019
  • Table 6.10: Outsourcing Clinical Trial Supply and Logistics: Advantages and Disadvantages, 2019
  • Table 7.1: Top Ten Prescription Drugs: Overall Biologics Share, 2015 and 2016
  • Table 7.2: Leading Providers of RFID Tags for the Pharmaceutical Market, 2019
  • Table 8.1: AmerisourceBergen: Other Service Revenue ($bn), 2015-2017
  • Table 8.2: DHL Supply Chain: Revenue ($m) by Sector, 2016
  • Table 8.3: DHL Life Sciences and Healthcare: Revenue ($m) and AGR (%), 2014-2016
  • Table 8.4: Marken Historical Revenue: Revenue ($m), Annual Growth (%),2015-2017
  • Table 8.5: Catalent Clinical Supply Services: Revenue ($m), 2015-2017
  • Table 8.6: Patheon Pharmaceutical Development Projects (%) by Phase, 2016
  • Table 8.7: Patheon Pharmaceutical Development Services: Revenue ($bn), 2014-2016
  • Table 8.8: Almac Group: Revenue ($m), 2014-2016
  • Table 8.9: Parexel: Clinical Research Services Revenue ($m), 2012-2016
  • Table 9.1: Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Sector, 2018, 2023 and 2029
  • Table 9.2: Clinical Trial Supply and Logistics Market: Revenue ($bn) and Market Share (%) by Region in 2018, 2023 and 2029

List of Figures

  • Figure 2.1: Sectors and Services in the Clinical Trial Supply and Logistics Market, 2018
  • Figure 2.2: Clinical Trials Registered by Location, 2018
  • Figure 2.3: Trends Affecting the Clinical Trial Supply and Logistics Market, 2019-2029
  • Figure 3.1: Pharma R&D Outsourcing Market: Market Share (%) by Sector, 2019
  • Figure 3.2: Clinical Trial Supply and Logistics Market: Market Share (%) by Sector, 2018
  • Figure 3.3: Clinical Trial Supply and Logistics Market Forecast ($bn), 2019-2029
  • Figure 3.4: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2023
  • Figure 3.5: Clinical Trial Supply and Logistics Market: Submarket Shares (%), 2029
  • Figure 3.6: Clinical Trial Supply and Logistics: Market Drivers, 2019-2029
  • Figure 3.7: Clinical Trial Supply and Logistics: Market Restraints, 2019-2029
  • Figure 3.8: Clinical Trial Manufacturing Market: Sector Shares (%), 2018
  • Figure 3.9: Clinical Trial Manufacturing Market Forecast ($bn), 2019-2029
  • Figure 3.10: Clinical Trial Manufacturing: Drivers and Restraints, 2019-2029
  • Figure 3.11: Clinical Trial Packaging Submarket Forecast ($bn), 2019-2029
  • Figure 3.12: Clinical Trial Logistics and Distribution Market: Sector Shares (%), 2018
  • Figure 3.13: Clinical Trial Logistics and Distribution Market Forecast ($bn), 2019-2029
  • Figure 3.14: Clinical Trial Logistics and Distribution: Drivers and Restraints, 2019-2029
  • Figure 3.15: Clinical Trial Cold Chain Logistics Submarket Forecast ($bn), 2019-2029
  • Figure 3.16: Clinical Trial Supply Chain Management Market Forecast ($bn), 2019-2029
  • Figure 3.17: Clinical Trial Supply Chain Management: Drivers and Restraints, 2019-2029
  • Figure 4.1: Clinical Trial Supply and Logistics Market: Market Share (%) by Country and Region, 2018
  • Figure 4.2: Clinical Trial Supply and Logistics Market: Market Share (%) by Region, 2018, 2023 and 2029
  • Figure 4.3: US Clinical Trial Supply and Logistics Market Forecast Revenue ($bn), 2019-2029
  • Figure 4.4: US Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.5: US Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.6: EU5 Clinical Trial Supply and Logistics: Overall Revenue Forecast ($bn), 2019-2029
  • Figure 4.7: EU5 Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.8: EU5 Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.9: The EU5 Clinical Trial Supply and Logistics Submarket Shares (%), 2018
  • Figure 4.10: Germany: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.11: France: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.12: The UK: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.13: Italy: Clinical Trial Supply and Logistics Market Revenue Forecast($bn), 2019-2029
  • Figure 4.14: Spain: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.15: Japan: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.16: Japanese Clinical Trial Supply and Logistics Market Share (%) in 2018, 2023 and 2029
  • Figure 4.17: Japanese Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.18: China: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.19: Chinese Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.20: Chinese Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.21: India: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.22: Indian Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.23: Indian Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.24: Brazil: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.25: Brazilian Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.26: Brazilian Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 4.27: Russia: Clinical Trial Supply and Logistics Market Revenue Forecast ($bn), 2019-2029
  • Figure 4.28: Russia: Clinical Trial Supply and Logistics Market Share (%), 2018, 2023 and 2029
  • Figure 4.29: Russian Clinical Trial Supply and Logistics: Drivers and Restraints, 2019-2029
  • Figure 6.1: Players in the Clinical Trial Supply Chain, 2019
  • Figure 8.1: AmerisourceBergen Other Service: Revenue ($bn), 2015-2017
  • Figure 8.2: DHL Supply Chain: Revenue Share (%) by Sector, 2016
  • Figure 8.3: Marken: Revenue ($m), 2015-2017
  • Figure 8.4: Catalent: Clinical Manufacturing Space by Region (%), 2017
  • Figure 8.5: Catalent Clinical Supply Services: Revenue ($m), 2015-2017
  • Figure 8.6: Patheon Pharmaceutical Development Projects (%) by Phase, 2016
  • Figure 8.7: Patheon Pharmaceutical Development Services: Revenue ($bn), 2014-2016
  • Figure 8.8: Almac Group: Revenue ($m), 2014-2016
  • Figure 8.9: Parexel: Clinical Research Services Revenue ($m), 2012-2016
  • Figure 9.1: Clinical Trial Supply and Logistics Market: Revenue ($bn) by Sector, 2018, 2023 and 2029
  • Figure 10.2: Clinical Trial Supply and Logistics Market: Revenue ($bn) by Region, 2018, 2023 and 2029

COMPANIES LISTED:

  • AbbVie Contract Pharmaceutical Manufacturing
  • Accucaps Industries Limited
  • ACM Global Central Lab
  • Agere Pharmaceuticals, Inc.
  • Allergan
  • Almac
  • Amatsigroup
  • AmerisourceBergen
  • Amgen
  • AndersonBrecon
  • Apax Partners
  • Aptuit
  • Astellas Pharma
  • AstraZeneca
  • Avepharm
  • Avogadro
  • Bellwyck Packaging Solutions
  • Bertin Pharma
  • BioClinica
  • Biotec Services International (Biotec)
  • Blackstone Group
  • Boehringer Ingelheim BioXcellence
  • Bristol-Myers Squibb
  • British Telecom (BT)
  • CAEN RFID
  • Cardinal Systems
  • Catalent Pharma Solutions
  • Celesio
  • Cenduit
  • Clínicos (CAIBER)
  • ClinIntel
  • ClinStar
  • COREX
  • Cortec
  • Cryoport
  • CSM
  • Custom Pharmaceuticals
  • DBI
  • DHL
  • Durbin
  • Ekkio Capital
  • Eli Lilly
  • EMD SERONO
  • EPS
  • ESMS
  • e-Trial Co.
  • Eurodifarm
  • Federal Express (FedEx)
  • Fisher Clinical Services
  • Frazier Healthcare
  • GE Healthcare
  • Greenbox
  • GSK
  • IBM
  • ICON
  • IMP Logistics
  • Intelleflex
  • Intelsius
  • Johnson & Johnson
  • Komtur Pharmaceuticals
  • LabCorp
  • LCAG USA
  • LifeConEx
  • Lonza
  • Marken
  • Mawdsleys
  • Medgenics
  • Merck & Co.
  • Micron Technologies
  • Millmount Healthcare
  • Mitsubishi Logistics
  • Mitsui & Co.
  • Movianto
  • Multipharma
  • NextPharma
  • Novo Nordisk
  • Novotech
  • N-SIDE
  • Nuvilex
  • Octapharma
  • Owens & Minor
  • Packaging Coordinators Inc. (PCI)
  • Parexel
  • Patheon N.V.
  • PCI Pharma Services
  • Penn Pharmaceutical
  • Perceptive Informatics
  • Pfizer
  • Pharmaceutical Trade Services Inc. (PTSI)
  • Pharmatek
  • Pieffe Group
  • PRA International
  • QBiologicals
  • Quintiles
  • Recipharm
  • Redwood BioScience
  • Roche
  • Sanofi
  • SF Express
  • ShangPharma
  • Sharp Packaging Services
  • Thermo Fisher Scientific
  • TNT Express
  • Touchdown International Ltd.
  • TransCelerate BioPharma
  • Tufts Center
  • UCB
  • United Parcel Service (UPS)
  • Vsoft Infoware
  • World Courier
  • Worldwide Clinical Trials
  • Y Prime

List of Organizations Mentioned in the Report:

  • Agência Nacional de Vigilância Sanitária (ANVISA)
  • Central Drugs Standard Control Organization (CDSCO)
  • China FDA (CFDA)
  • Chinese Ministry of Health
  • Comissão Nacional de Ética em Pesquisa (CONEP)
  • Consorcio de Apoyo a la Investigación Biomédica - Plataforma Española de Ensayos Clínicos (CAIBER)
  • Drug Controller General of India (DCGI)
  • European Commission
  • European Medicines Agency (EMA)
  • Food and Drug Administration (FDA)
  • Health Science Authority
  • International Air Transport Association (IATA)
  • International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)
  • International Pharmaceutical Federation
  • Japanese Ministry of Health, Labour and Welfare (MHLW)
  • Les Enterprises du Medicament (LEEM)
  • Medicines and Healthcare Products Regulatory Agency (MHRA)
  • National Institutes of Health (NIH)
  • Pharmaceuticals for Human Use (ICH)
  • Transportation Administration Security (TAS)
  • US Pharmacopeia (USP)
  • World Health Organization (WHO)
目次
Product Code: PHA0415

The global clinical trial supply and logistics market for pharma is estimated to have reach $17.1bn in 2018, dominated by the clinical trial manufacturing segment. The global clinical trial supply and logistics market for pharma is expected to grow at a CAGR of 7.7% in the first half of the forecast period.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 123 charts- all unavailable elsewhere.

The 204-page report provides clear detailed insight into the global clinical trial supply and logistics market for pharma. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Revenue and growth forecasts from 2019 to 2029 for the global clinical trial supply and logistics market. This report also discusses the Drivers and Restraints of the global clinical trial supply and logistics market.

Revenue and growth forecasts from 2019 to 2029 for the leading submarkets of the global clinical trial supply and logistics market:

  • Manufacturing - also with sub forecasting for packaging and for other production
  • Logistics and distribution - also with sub forecasts for cold chain logistics and for other services
  • Supply chain management

This report discusses the Drivers and Restraints of each submarket.

Revenue and growth forecasts from 2019 to 2029 for the leading national markets:

  • United States
  • Japan
  • EU5: Germany, France, United Kingdom, Italy, Spain
  • Brazil
  • Russia
  • China
  • India
  • Rest of the World

Revenues forecast for the US, Japan, EU5, Brazil, Russia, China, India are further broken down by submarket.

This report profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry:

  • ADAllen Pharma
  • Almac Group
  • Amatsigroup
  • Biocair International Limited
  • Catalent
  • DHL
  • Durbin PLC
  • FedEx
  • Fisher Clinical Services
  • Marken
  • Movianto
  • Packaging Coordinators Inc.
  • Parexel International
  • Patheon
  • Sharp Packaging Services, LLC
  • TNT Express
  • World Courier

This report provides qualitative analysis of the clinical trial supply and logistics market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the clinical trial supply and logistics market. Social, Technological, Economic and Political factors that influence this market are also discussed.

This report discusses trends in the clinical trial supply and logistics market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management.

This report discusses the regulatory outlook of the clinical trial supply and logistics industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials

Key Questions Answered by this Report:

  • How is the clinical trial supply and logistics market for pharma evolving?
  • What are the drivers and restraints for the growth of the clinical trial supply and logistics market for pharma?
  • How will each clinical trial supply and logistics submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2029?
  • How will the market shares for each clinical trial supply and logistics submarket for pharma develop to 2029?
  • What is the value of the leading clinical trial supply and logistics submarket for pharma s in important regions of the world?
  • What will be the main driver for the overall market to 2029?
  • How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029?
  • Who are the leading players and what are their prospects over the forecast period?

Visiongain's study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market for pharma. You find data, trends and predictions.

Buy our report today Clinical Trial Supply and Logistics Market for Pharma 2019-2029: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Overview of the World Market for Clinical Trial Supply and Logistics
  • 1.2. Benefits of This Report
  • 1.3. How This Report Delivers
  • 1.4. Main Questions Answered by This Analysis
  • 1.5. Who Is This Study For?
  • 1.6. Methods of Research and Analysis
  • 1.7. Frequently Asked Questions (FAQs)
  • 1.8. Some Related Reports
  • 1.9. About Visiongain

2. Defining the Clinical Trial Supply and Logistics Market

  • 2.1. An Introduction to the Clinical Trial Supply and Logistics Market
  • 2.2. Clinical Trials are Becoming Increasingly Complex
  • 2.3. Clinical Trial Globalisation: Access to New Markets and New Patients
  • 2.4. Outsourcing Clinical Trial Supply and Logistics
  • 2.5. What Services Are Most Commonly Outsourced?
  • 2.6. Which Companies Participate in the Clinical Trial Supply and Logistics Market?
  • 2.7. Clinical Trial Supply and Logistics: Trends and Future Outlook

3. Clinical Trial Supply and Logistics: World Market Outlook and Forecasting 2019-2029

  • 3.1. The World Clinical Trial Supply and Logistics Market 2018
    • 3.1.1. Which Were the Leading Market Sectors in 2018?
  • 3.2. The World Clinical Trial Supply and Logistics Market Forecast 2019-2029
    • 3.2.1. What Will Drive Market Growth to 2029?
    • 3.2.2. Clinical Trial Supply and Logistics: Market Restraints 2019-2029
  • 3.3. Clinical Trial Manufacturing Submarket 2019-2029
    • 3.3.1. Outlook and Forecast for the Clinical Trial Manufacturing Submarket 2019-2029
    • 3.3.2. Complex Manufacturing and Packaging to Drive Growth 2019-2029
    • 3.3.3. Clinical Trial Packaging Submarket Forecast 2019-2029
  • 3.4. Clinical Trial Logistics and Distribution Submarket 2019-2029
    • 3.4.1. Clinical Trial Logistics and Distribution Submarket Forecast 2019-2029
    • 3.4.2. Clinical Trial Logistics and Distribution: Drivers and Restraints 2019-2029
    • 3.4.3. Clinical Trial Cold Chain Distribution Submarket Forecast 2019-2029
  • 3.5. Clinical Trial Supply Chain Management Submarket 2019-2029
    • 3.5.1. Clinical Trial Supply Chain Management Submarket Forecast 2019-2029
    • 3.5.2. Drivers and Restraints for the Clinical Trial Supply Chain Management Submarket 2019-2029

4. Leading National Markets for Clinical Trial Supply and Logistics 2019-2029

  • 4.1. Defining National Submarkets for Clinical Trial Supply and Logistics
  • 4.2. Leading National Submarkets for Clinical Trial Supply and Logistics 2018
    • 4.2.1. How Will These Leading Submarkets Grow during 2019-2029?
  • 4.3. The US: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.3.1. How Will Demand for Clinical Trial Logistics Grow in the US to 2029?
    • 4.3.2. US Clinical Trial Supply and Logistics Submarket
  • 4.4. EU5. Markets for Clinical Trial Supply and Logistics, 2019-2029
    • 4.4.1. The Clinical Trial Supply and Logistics Market for Germany: 2019-2029
    • 4.4.2. France: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.4.3. The UK: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.4.4. Italy: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.4.5. Spain: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.4.6. EU5 Clinical Trial Supply and Logistics Submarket
  • 4.5. Japan: A New and Growing Market for Outsourced Logistics
    • 4.5.1. Japanese Clinical Trial Supply and Logistics Submarket Forecast 2019-2029
    • 4.5.2. Japanese Clinical Trial Supply and Logistics Submarket
  • 4.6. Clinical Trials Increasing Demand in Emerging National Markets
  • 4.7. China: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.7.1. Foreign Investment in Chinese Clinical Trial Logistics
    • 4.7.2. Strong Growth for Clinical Trial Supply and Logistics in China 2019-2029
    • 4.7.3. Chinese Clinical Trial Supply and Logistics Submarket
  • 4.8. India: An Emerging Destination for Outsourced Clinical Trials
    • 4.8.1. India: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.8.2. Indian Clinical Trial Supply and Logistics Submarket
  • 4.9. The Latin American Clinical Trial Supply and Logistics Market
    • 4.9.1. Challenging Distribution Conditions
    • 4.9.2. Brazil: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.8.3. Brazil Clinical Trial Supply and Logistics Submarket
  • 4.10. Russia: Clinical Trial Supply and Logistics Market, 2019-2029
    • 4.10.1. Russia Benefiting from Close Proximity to European Union
    • 4.10.2. Outsourcing Will Grow Strongly in Russia
    • 4.10.3. Russia Clinical Trial Supply and Logistics Submarket

5. Clinical Trial Supply and Logistics: Regulatory Outlook 2019-2029

  • 5.1. How do Regulatory Standards Affect Clinical Trial Supply?
    • 5.1.1. Good Practices (GxP) in Clinical Trial Distribution
  • 5.1.1.1. Good Manufacturing Practice (GMP)
  • 5.1.1.2. Good Distribution Practice (GDP)
    • 5.1.2. Import Regulations Complicate International Manufacturing and Trials
  • 5.2. Clinical Trial Supply Regulations in the US 2018
    • 5.2.1. Importing Drugs into the US: A Reinterpretation of the Rules
  • 5.3. Clinical Trial Regulations in the EU 2018
    • 5.3.1. Manufacturing Requirements for Clinical Trial Materials in the EU
    • 5.3.2. The European Commission Releases New GDP Guidelines 2013
  • 5.4. GMP and Importation Regulations for Pharmaceuticals in Japan 2017
  • 5.5. Clinical Trial Supply Chain Regulations in Emerging Markets
    • 5.5.1. China: Tougher Regulations for Pharmaceutical Companies and Service Providers
      • 5.5.1.1. Improving Supply Chain Security in China 2018
    • 5.5.2. India: Drug Manufacturing and Imports for Clinical Trials
      • 5.5.2.1. The CDSCO Drafts New GDP Guidelines
    • 5.5.3. Brazil: Slow Regulatory Approval for Clinical Trials
    • 5.5.4. Recent Updates to Pharmaceutical Regulation in Russia

6. Clinical Trial Supply and Logistics: Industry Trends 2019-2029

  • 6.1. Clinical Trial Supply and Logistics Market: Strengths and Weaknesses 2018
  • 6.2. Clinical Trial Supply and Logistics Market: Opportunities and Threats 2019-2029
  • 6.3. Clinical Trial Supply and Logistics Market: STEP Analysis 2019-2029
    • 6.3.1. Social Factors
    • 6.3.2. How Will Novel Technologies Affect the Market to 2029?
    • 6.3.3. Economic Pressure: Demands for Lower Cost Trials and Logistics
    • 6.3.4. Political Issues
  • 6.4. Securing the Clinical Trial Supply Chain 2019-2029
    • 6.4.1. How Will Technology Improve Supply Chain Security?
  • 6.5. How Will Clinical Trial Globalisation Impact Supply and Logistics?
  • 6.6. Trends in Clinical Trial Manufacturing 2019-2029
    • 6.6.1. The Challenge of Comparator Sourcing for Clinical Trials
      • 6.6.1.1. Comparators Are a Source of Risk for Supply Chain Security
      • 6.6.1.2. Regulators and Payers Will Increasingly Demand Comparative Effectiveness Research
    • 6.6.2. Trends in Packaging for Clinical Trials 2019-2029
  • 6.7. Clinical Trial Supply Chain Management Trends to 2029
    • 6.7.1. Forecasting and Modelling to Ensure Sufficient Supply
    • 6.7.2. IT Systems Improve Clinical Trial Planning: IVRS and IWRS
    • 6.7.3. Home-Based Trial Participation: Opportunities and Challenges for Logistics
    • 6.7.4. How Will Greater Use of Adaptive Clinical Trials Impact Trial Logistics?
  • 6.8. Outsourcing Clinical Trial Supply and Logistics
    • 6.8.1. Managing Multiple Supplier Networks

7. The Rise of Cold Chain Logistics in Clinical Trials 2019-2029

  • 7.1. An Introduction to Cold Chain Supply and Distribution
    • 7.1.1. The Importance of Cold Chain for Clinical Trials
    • 7.1.2. Maintaining the Cold Chain
  • 7.2. The Regulatory Outlook for Cold Chain Logistics
    • 7.2.1. International Air Transport Regulations and Guidance: The Temperature Sensitive Label
  • 7.3. Cold Chain Will Account for an Increasing Proportion of Clinical Trial Logistics 2019-2029
    • 7.3.1. Biologic Drug Development Will Stimulate Demand
      • 7.3.1.1. Emerging Trends in Biological Drug Development
    • 7.3.2. Pharma Cold Chain Logistics in Emerging Markets
  • 7.4. The Role of Technology in Clinical Cold Chain Logistics
    • 7.4.1. Active and Passive Temperature Control
    • 7.4.2. There Are Many Ways to Maintain Temperature in the Cold Chain
      • 7.4.2.1. Developments in Phase Change Materials
      • 7.4.2.2. The Benefits of Liquid Nitrogen for Sample Transportation
    • 7.4.3. Advances in RFID for Temperature Monitoring
      • 7.4.3.1. Will Uptake for RFID Grow Among Biopharma Companies to 2029?
    • 7.4.4. Future Technologies for Cold Chain Supply Management
      • 7.4.4.1. Demand for Reusable Cold Chain Packaging

8. Clinical Trial Supply and Logistics Market: Leading Companies

  • 8.1. Third Party Logistics Providers: Leading Clinical Distributors
    • 8.1.1. World Courier: A Pharmaceutical Supply Specialist
      • 8.1.1.1. Distribution Services for Pharma, CROs and Central Laboratories
      • 8.1.1.2. World Courier Is the Clinical Trial Distribution Market Leader
      • 8.1.1.3. World Courier Service Expansion
    • 8.1.2. DHL: A Global Leader in Supply Chain Logistics
      • 8.1.2.1. Life Sciences: A Fast-Growing Source of Revenue for DHL Supply Chain
      • 8.1.2.2. DHL: Services for Healthcare and Clinical Trial Clients
    • 8.1.3. Marken: A leader in Direct to Patient Services
      • 8.1.3.1. What Services Does Marken Offer Clinical Trial Sponsors?
      • 8.1.3.2. Marken: Challenging Market Conditions 2010-2015
      • 8.1.3.3. Marken Continues to Expand Worldwide
      • 8.1.3.4. Expertise in Biological Sample Management
    • 8.1.4. Other Leading and Emerging Players in the Market 2018
      • 8.1.4.1. FedEx
      • 8.1.4.2. Biocair International Limited
      • 8.1.4.3. Movianto - A European Healthcare Specialist
  • 8.2. Clinical Trial Manufacturing: Submarket Leaders
    • 8.2.1. Catalent Pharma Solutions
      • 8.2.1.1. Clinical Trial Manufacturing and Supply Services
      • 8.2.1.2. Strong Growth for Clinical Manufacturing Revenue
      • 8.2.1.3. Catalent Expanding its Clinical Supply Services
    • 8.2.2. Patheon N.V.
      • 8.2.2.1. Patheon - Global leader in Pharmaceutical Development Services
    • 8.2.3. Almac Group: Manufacturing, Packaging and Logistics Services
      • 8.2.3.1. Clinical Trial Supply and Management Solutions
      • 8.2.3.2. Almac Opens New Facilities to Expand its Clinical Trial Expertise
    • 8.2.4. Amatsigroup SAS:
  • 8.3. The Role of CROs in the Clinical Trial Supply and Logistics Market
    • 8.3.1. PAREXEL International Corp.
      • 8.3.1.1. Parexel's Clinical Trial Supply and Logistics Services
      • 8.3.1.2. Parexel Expands Worldwide
  • 8.4. Other Leading Companies in the Clinical Trial Supply and Logistics Market 2018
    • 8.4.1. Fisher Clinical Services (FCS)
      • 8.4.1.1. FCS Offers Manufacturing, Packaging, Storage and Distribution Services
      • 8.4.1.2. Fisher BioServices: Clinical Logistics for the Cell Therapy Industry
    • 8.4.2. Packaging Coordinators Inc. (PCI)
    • 8.4.3. ADAllen Pharma
    • 8.4.4. Sharp Packaging Services, LLC
    • 8.4.5. Durbin PLC

9. Conclusions of Our Study

  • 9.1. The Clinical Trial Supply and Logistics Market in 2018
  • 9.2. Outlook for the Market, 2019-2029
  • 9.3. Growing Demand for Clinical Logistics in Emerging Countries
  • 9.4. Technology and Innovation to Drive Outsourcing

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Report Evaluation Form
Back to Top